GOING CONCERN (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 04, 2025 |
Aug. 18, 2025 |
Jul. 13, 2022 |
Apr. 30, 2026 |
Jan. 31, 2026 |
Mar. 31, 2026 |
Dec. 31, 2025 |
Sep. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2024 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| SubstantialDoubtAboutGoingConcernLineItems [Line Items] | |||||||||||||||
| Net loss | $ 6,360,336 | $ 3,091,394 | $ 4,837,738 | $ 54,067,346 | $ 430,183 | $ 354,310 | $ 14,289,468 | $ 54,851,839 | $ 58,923,300 | $ 1,820,528 | |||||
| Net cash used in operations | 4,080,653 | 312,982 | 405,168 | 935,118 | |||||||||||
| Working capital deficit | 140,843,234 | 140,843,234 | 125,621,520 | ||||||||||||
| Gross proceeds | $ 24,711 | $ 3,314,458 | 23,057 | ||||||||||||
| Series C Preferred Stock [Member] | |||||||||||||||
| SubstantialDoubtAboutGoingConcernLineItems [Line Items] | |||||||||||||||
| Shares of common stock | 100 | ||||||||||||||
| Warrants to purchase of shares | 9,900 | ||||||||||||||
| Exercise price | $ 10,000 | ||||||||||||||
| Cash payment of warrants | $ 1,000,099 | ||||||||||||||
| Common Stock [Member] | |||||||||||||||
| SubstantialDoubtAboutGoingConcernLineItems [Line Items] | |||||||||||||||
| Net loss | |||||||||||||||
| Shares of common stock | 40,000 | 183,655 | 20,437 | 40,000 | 136,345 | 13 | |||||||||
| Gross proceeds | $ 4,000,000 | ||||||||||||||
| Net proceeds | $ 3,300,000 | ||||||||||||||
| Common Stock [Member] | Subsequent Event [Member] | |||||||||||||||
| SubstantialDoubtAboutGoingConcernLineItems [Line Items] | |||||||||||||||
| Shares of common stock | 40,000 | 84,000 | |||||||||||||
| Gross proceeds | $ 4,000,000 | ||||||||||||||
| Net proceeds | $ 3,340,000 | ||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of Working capital (Deficiency) as of the Balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|